These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28854515)

  • 1. Intravenous immunoglobulin in the management of a rare cause of hemolytic disease of the newborn: Anti-SARA antibodies.
    Venkataraman R; Yusuf K
    J Neonatal Perinatal Med; 2017; 10(3):329-332. PubMed ID: 28854515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of hemolytic disease of the newborn infant due to anti-K (Cellano).
    Moncharmont P; Juron-Dupraz F; Doillon M; Vignal M; Debeaux P
    Acta Haematol; 1991; 85(1):45-6. PubMed ID: 2011931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
    Huang WM; Chen HW; Li N; Yang M; Jiao PY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
    Onesimo R; Rizzo D; Ruggiero A; Valentini P
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male newborn with anti-Kg antibody-induced hemolytic disease of the newborn.
    Kubo S; Takahashi J; Yoshizawa H; Ohgitani A; Ezaki T; Tsubaki K; Tani Y; Minowa H
    Pediatr Int; 2009 Aug; 51(4):582-4. PubMed ID: 19674370
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients.
    Fernández-Jiménez MC; Jiménez-Marco MT; Hernández D; González A; Omeñaca F; de la Cámara C
    Vox Sang; 2001 Feb; 80(2):117-20. PubMed ID: 11348543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
    Towns D; Hannon J; Hendry J; Barnes J; Goldman M
    Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
    Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
    Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases].
    Gao XY; Huang H; Li LD
    Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):648-52. PubMed ID: 20021783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka.
    Mandal S; Malhotra S; Negi G; Tiwari A; Mitra S; Basu S; Singh P
    Immunohematology; 2020 Jun; 36(2):60-63. PubMed ID: 32667819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden.
    Filbey D; Hanson U; Wesström G
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):687-92. PubMed ID: 7572101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature.
    Squires A; Nasef N; Lin Y; Callum J; Khadawardi EM; Drolet C; Core D; Simmons B
    Neonatal Netw; 2012; 31(2):69-80. PubMed ID: 22397791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of ABO hemolytic disease in the newborn infant].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(3):253-7. PubMed ID: 6992621
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on HDFN: new information on long-standing controversies.
    Eder AF
    Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.